As of Oct 21
| -0.11 / -1.56%|
The 4 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 15.00, with a high estimate of 30.00 and a low estimate of 15.00. The median estimate represents a +116.45% increase from the last price of 6.93.
The current consensus among 4 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.